Species : |
Human |
Source : |
Insect Cells |
Tag : |
His |
Description : |
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A (this protein) and BMPR1B and the type II receptor BMPR2. Cellular responses to bone morphogenetic proteins (BMPs) have been shown to be mediated by the formation of hetero-oligomeric complexes of the type I and type II serine/threonine kinase receptors. BMP receptor 1A (BMPR-1A), also known as activin receptor-like kinase (ALK)-3, is a one of seven known type I serine/threonine kinases that are required for the signal transduction of TGF-b family cytokines. In contrast to the TGF-b receptor system in which the type I receptor does not bind TGF-b in the absence of the type II receptor, type I receptors involved in BMP signaling (including BMPR-IA, BMPR-IB/ALK-6, and ActR-I/ALK-2) can independently bind the various BMP family proteins in the absence of type II receptors. Recombinant soluble BMPR-IA binds BMP-2 and -4 with high-affinity in solution and is a potent BMP-2/4 antagonist in vitro. |
Purity : |
>90% by SDS-PAGE and silver staining. |
Endotoxin level : |
<0.1ng per μg of BMPRIA. |
Buffer : |
PBS. |
Stabilizer : |
None. |
Formulation : |
Lyophilized. |
Biologically Activity : |
Measured by its ability to inhibit recombinant human BMP-2 induced alkaline phosphatase production by C2C12 myogenic cells. The ED50 for this effect is typically 1-3 μg/ml in the presence of 500 ng/ml of recombinant human BMP-2. |
Reconstitution : |
It is recommended that sterile PBS containing at least 0.1% HSA or BSA be added to the vial to prepare a stock solution of no less than 100 μg/ml of BMPR-IA. |
Stability : |
Lyophilized samples are stable for greater than six month at -20°C to -70°C. Upon reconstitution, this cytokine can be stored under sterile conditions at -2°C to -4°C for one month or at -20°C to -70°C for three month without detecable loss of activity. Avoid repeated freeze–thaw cyles. |